A Medigene platform · Omnichannel HCP engagement

One knowledge network for everyone in the care chain

A prescription travels from the doctor who writes it, to the pharmacist who dispenses it, with a field representative connecting both. MedShorts gives all three the same accurate, bite-sized science, through one personalised link they can open on any phone.

Who MedShorts servesProgrammes for pharma

The MedShorts network

DoctorsClinical updates in five minutes or less
PharmacistsDispensing, counselling and safety capsules
Field forceProduct knowledge, certification and shareable links
One dashboardReach, engagement and learning, by audience
MedShorts 360 · Latest

Latest news, 16 November 2026

One new story for each specialty, every morning: short, sourced and readable between patients.

CardiologyCardiology

Empagliflozin eases angina in ANOCA with microvascular dysfunction in small pilot study

In an 11-patient open-label pilot, 90 days of empagliflozin 10 mg raised Seattle Angina Questionnaire scores by 14 points and shifted endothelial and inflammatory markers favourably in angina with no obstructive coronary arteries.

Medical Dialogues
DiabetologyDiabetology

IL-6, not hs-CRP, independently predicts heart failure in type 2 diabetes with obesity: Look AHEAD

A post hoc Look AHEAD analysis found each 1-SD rise in log IL-6 was linked to 43% higher heart failure risk, independent of standard risk factors, while hs-CRP was not; lifestyle intervention cut IL-6 by 28.7% at one year.

Medical Dialogues
NephrologyNephrology

Creatinine-based eGFR misses nearly half of CKD in patients with solid tumours, ASN study finds

In 1,200 adults with solid tumours, measured GFR identified CKD in 18.9% versus 10.2% by creatinine eGFR and 15.7% with added cystatin C, raising concern about dosing of renally cleared anticancer drugs.

Medical Dialogues
NeurologyNeurology

Glucosamine use linked to faster MCI-to-dementia progression in records study, Nature Metabolism

In Florida health records, glucosamine users with mild cognitive impairment had 25% higher odds of progressing to dementia, and users with dementia 25% higher mortality; mouse and brain-tissue work implicated hyperglycosylation. Findings are associative.

Medical Dialogues
UrologyUrology

Red ginseng oil 500 mg/day improves moderate LUTS and erectile scores in 12-week placebo-controlled trial

In a randomised, double-blind trial of 100 men aged 50 or older with moderate LUTS, red ginseng oil 500 mg/day lowered IPSS to 6.76 versus 11.64 with placebo at 12 weeks, with better IIEF-5 scores and no serious adverse events.

Medical Dialogues
PsychiatryPsychiatry

Maternal depression, more than antidepressant use, linked to neurodevelopmental needs in Welsh children

In a Welsh cohort of over 167,000 children, special educational needs rose from 20 per 100 with no exposure to 24 per 100 with untreated maternal depression; antidepressant use added about 3 per 100, possibly reflecting more severe depression.

Medical Dialogues
PulmonologyPulmonology

Poor oral hygiene and weak secretion clearance flag pneumonia risk during NIV in respiratory ICU

In a Turkish prospective study of 191 respiratory ICU patients on non-invasive ventilation, 44% developed NIV-associated pneumonia; poor oral hygiene and difficulty clearing secretions (adjusted OR 3.86), not age, were independently linked.

Medical Dialogues
Critical CareCritical Care

Indian study: five-item frailty index predicts ICU admission and one-year death after hip fracture surgery

In 138 older adults operated for hip fracture at an Indian tertiary hospital, the 5-point modified frailty index correlated with ICU admission and ICU stay, and high frailty predicted poorer one-year survival; overall one-year mortality was 16.7%.

Medical Dialogues
GastroenterologyGastroenterology

Updated meta-analysis links PPIs to 18% higher dementia risk, but no excess versus H2 blockers

Pooling 23 longitudinal studies in older adults, PPI use was associated with an 18% higher dementia risk overall, but risk was similar to H2-receptor antagonist users (HR 1.04), and estimates varied with comparator and bias handling.

Medical Dialogues
DermatologyDermatology

Salicylic acid peels plus topical zinc clear Malassezia folliculitis in 95% in multicentre single-arm trial

In 240 adults with moderate-to-severe Malassezia folliculitis, weekly 30% supramolecular salicylic acid peels plus daily 1% active zinc for 8 weeks gave 95.4% overall efficacy, with 0.84% recurrence at 4 weeks and 2.9% adverse effects.

Medical Dialogues
OphthalmologyOphthalmology

Bimatoprost-releasing intraocular lens matches timolol drops at one year after cataract surgery

In a phase 1/2 masked trial of 106 patients with glaucoma or ocular hypertension having cataract surgery, bimatoprost-eluting lenses lowered eye pressure to 14.8-15.9 mmHg at 12 months, similar to timolol, and over 95% needed no drops.

Medical Dialogues
ENTENT

Indian meta-analysis: liquid biopsy detects oral squamous cell carcinoma with pooled AUC of 0.87

Pooling 18 studies with 8,772 participants, blood and saliva liquid biopsy showed pooled sensitivity of 77.7% and specificity of 80.3% for oral squamous cell carcinoma, with ctDNA performing best (80.5% and 84.0%).

Medical Dialogues
OrthopaedicsOrthopaedics

Adding a fourth transverse alpha screw speeds healing in vertical femoral neck fractures, retrospective study

In 60 adults aged 18-65 with vertically oriented femoral neck fractures, a four-screw construct healed in 14.6 vs 15.9 weeks with three screws, with better early hip scores and less pain, at the cost of longer surgery and more fluoroscopy.

Medical Dialogues
GynaecologyGynaecology

Local infiltration start halves decision-to-delivery time in crash caesarean but outcomes unchanged

In 88 category I caesareans, starting surgery under local infiltration with non-intubated general anaesthesia after delivery cut median decision-to-delivery time to 9 vs 26 minutes, without better Apgar scores and with more blood loss.

Medical Dialogues
PaediatricsPaediatrics

Children with eczema more likely to have a diagnosed sleep disorder, ACAAI 2026 records study

Among more than 26,000 children seen in an urban primary care clinic, about 15% had eczema; 12% of those with eczema had a diagnosed sleep problem versus 10% without, independent of mental health or other allergic conditions.

Medical Dialogues
SurgerySurgery

Intraoperative dobutamine plus norepinephrine cuts postoperative AKI in septic shock surgery: JAMA trial

In a 584-patient randomised trial across 39 Chinese hospitals, adding dobutamine to norepinephrine during surgery for septic shock lowered new or worsening AKI to under 25% versus about 35%, with more tachycardia but no rise in serious complications.

Medical Dialogues
General MedicineGeneral Medicine

Preterm birth, SGA and pregnancy hypertension linked to higher lifelong PAD risk in women

A Swedish cohort of 2.2 million women followed for up to 46 years found adverse pregnancy outcomes, including SGA birth (aHR 1.74), preterm delivery (aHR 1.58) and pre-eclampsia (aHR 1.28), predicted later peripheral artery disease.

Medical Dialogues
17 new today · 17 latest storiesSee all MedShorts 360 stories →
Get the MedShorts app

Add MedShorts to your phone's home screen: today's stories in one tap, full screen, no app store needed.

Why MedShorts is changing

Medical communication has outgrown the single doctor visit

Indian pharma has traditionally put almost all of its scientific effort into one moment: the representative's few minutes with a doctor. Yet outcomes depend on much more than that moment. The pharmacist decides how a medicine is explained, substituted and taken. The representative's own confidence in the science shapes every conversation. And the doctor, seeing dozens of patients a day, needs updates that fit between consultations, not another hour-long webinar.

MedShorts began as a smart way to send doctors a personalised content library through a single link. We are now extending it into a broader strategic initiative: a knowledge network that serves the doctor, the pharmacist and the field force together, with consistent science, the right depth for each role, and one view of engagement for the brand team.

The result is fewer disconnected campaigns and more joined-up education, where the doctor's prescription, the pharmacist's counselling and the representative's message all say the same thing.

What changes with MedShorts

01
From one audience to threeContent written separately for prescribers, dispensers and representatives, from the same evidence base.
02
From campaigns to a programmeA planned calendar of short updates across the year instead of one-off mailers.
03
From clicks to insightEngagement data by specialty, geography and audience, fed back into the next cycle.
04
From information to learningQuizzes, certification and links to Medigene CME where a deeper course exists.
Who MedShorts serves

Built for three roles that shape every treatment

Each audience gets its own experience, written for how they work and what they need to decide, while the science underneath stays the same.

For doctors

Clinical knowledge between consultations

Short clinical updates, guideline summaries, journal digests and KOL perspectives, curated by specialty and delivered to the phone.

  • Read or watch in under five minutes
  • Specialty-specific libraries
  • Patient education material to share
MedShorts for doctors →
For pharmacists

Confident counselling at the counter

Practical capsules on dosing, interactions, storage, adherence and safety, written for community and hospital pharmacists.

  • Counselling scripts and checklists
  • Drug interaction and safety alerts
  • Available in English and Hindi
MedShorts for pharmacists →
For field force

Scientific confidence in every call

Micro-learning on disease, molecule and evidence, with assessments, certification and approved links representatives can share with doctors.

  • Daily five-minute learning bursts
  • Quizzes and product certification
  • Compliant, trackable sharing
MedShorts for field force →
The connected care chain

One message, from the representative to the patient

When all three roles learn from the same source, the patient hears one consistent story about their treatment.

Field representative

Learns the evidence, passes certification, shares an approved MedShorts link.

Doctor

Reviews the update in minutes, prescribes with the latest guidance, shares patient material.

Pharmacist

Dispenses correctly and counsels on dose, timing, side-effects and adherence.

MedShorts hubShared evidence base, medical review, multi-language content and one analytics layer across all three audiences.See the programme model
Strategic pillars

Five things MedShorts is built on

Short, evidence-led content

Every piece is written from published evidence and guidelines, reviewed by our medical team and kept to the length a busy clinician will actually finish.

Reach where people already are

Personalised links by SMS, email and WhatsApp, QR codes at pharmacies and clinics, and representative-shared links. No app to download.

Learning, not just reading

Quizzes, case challenges and certification turn content into measurable learning, with deeper courses on Medigene Learn.

Insight for brand teams

Open, read-through, video-completion and quiz data by audience, specialty and region, reported in one dashboard.

Trust and compliance

Medical and regulatory review, content aligned with the approved prescribing information, consent-based contact and data handled under India's data-protection law.

India-first delivery

Designed for low-bandwidth mobile use, with English and Hindi as standard and regional languages for pharmacist and patient material.

How it works

Receive, open, learn, act

Receive

A personalised MedShorts link arrives by SMS, email or WhatsApp, or is shared by a representative.

Open

One tap opens a secure, mobile-friendly library. A one-time registration keeps it personal.

Learn

Short articles, videos, infographics and quizzes, chosen for the reader's role and specialty.

Act

Apply it in practice, share patient material, or continue to a full CME course.

Measure

Engagement flows into the brand dashboard and shapes the next content cycle.

Content formats

The right format for every minute available

Clinical shorts

Two-to-three-minute reads on a single clinical question.

KOL video bites

Expert perspectives in three-to-five-minute clips.

Journal digests

Landmark and recent trials summarised with key numbers.

Guideline snapshots

What changed, and what it means in clinic.

Quizzes & case challenges

Test and reinforce, with instant explanations.

Patient education

Leaflets and videos doctors and pharmacists can share.

Interactive tools

Lung-sound and ECG trainers, calculators and checklists.

Safety alerts

Interaction, storage and pharmacovigilance reminders.

Already live

A growing library across specialties

MedShorts already hosts series in neurology, cardio-metabolic care, respiratory medicine, orthopaedics, oncology, women's health, critical care, dermatology, dentistry and ophthalmology, including interactive trainers for lung sounds and ECG interpretation.

The new network brings these together in one library and adds dedicated tracks for pharmacists and field teams.

NeurologyCardio-metabolicRespiratoryOrthopaedicsOncologyWomen's healthCritical careDermatologyDentalOphthalmology

Browse the content library

Fewer, shorter and better-targeted messages, shared by everyone around the patient, do more than any single detailing call.The idea behind the MedShorts network

Bring your brand science to the whole care chain

Talk to us about a MedShorts programme that reaches your doctors, their pharmacists and your field force with one consistent, compliant message.

Talk to our team